Reported about 1 year ago
Goldman Sachs anticipates difficulties in stock picking due to rising bond yields and high valuations impacting equity markets, with strategist Peter Oppenheimer suggesting diversification for investors in a flat market. Despite this, Goldman analysts recommend Jazz Pharmaceuticals (JAZZ) and Zeekr Intelligent Technology (ZK) as Strong Buy stocks with notable growth potential. JAZZ, a biotech firm with successful approved medications and a promising pipeline, is endorsed for its quality pipeline and trading at a discount, offering a 55% upside potential. On the other hand, ZK, a luxury EV brand partly owned by Geely, is praised for its asset-light manufacturing model and cost-efficient operations, leading to a 44% one-year upside potential. Both stocks have a Strong Buy consensus among the analysts surveyed.
Source: YAHOO